AMLX
Amylyx Pharmaceuticals, Inc.$17.69-0.48 (-2.64%)Prev Close$18.20·MCap$1.51B·P/E—·Vol689.2K·Yield—
▲
Buys (12M)
2
$152.2K
▼
Sells (12M)
26
$11.20M
◆
Net Activity
Net Seller
$11.05M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Amylyx Pharmaceuticals, Inc. (AMLX) has been dominated by selling, with 2 insider purchases totaling $152.2K and 26 insider sales totaling $11.20M. The most recent insider transaction was by Mazzariello Gina (officer: Chief Legal Officer), who sold $538.9K worth of shares on Jul 13, 2026. Amylyx Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.51B.
AMLX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Mazzariello Gina | officer: Chief Legal Officer | Sell | 30,000 | $17.96 | $538.9K | 194,090 |
| May 26, 2026 | Firestone Karen | director | Buy | 3,800 | $13.51 | $51.3K | 66,900 |
| Feb 25, 2026 | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,419 | $14.14 | $48.4K | 141,274 |
| Feb 4, 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 3,363,965 |
| Feb 4, 2026 | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 173,547 |
| Feb 4, 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 3,363,898 |
| Feb 4, 2026 | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 144,693 |
| Feb 2, 2026 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 0 |
| Feb 2, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 0 |
| Feb 2, 2026 | Klee Justin B. | Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 0 |
| Feb 2, 2026 | Mazzariello Gina | Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 0 |
| Jan 20, 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 3,379,465 |
| Jan 20, 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 3,379,398 |
| Jan 15, 2026 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 0 |
| Jan 15, 2026 | Klee Justin B. | Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 0 |
| Jan 8, 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,632 |
| Jan 8, 2026 | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 177,104 |
| Jan 8, 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,586 |
| Jan 6, 2026 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 0 |
| Jan 6, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 0 |
| Dec 23, 2025 | Firestone Karen | Director | Buy | 8,100 | $12.45 | $100.8K | 0 |
| Dec 1, 2025 | Bedrosian Camille L | Chief Medical Officer | Sell | 6,580 | $14.35 | $94.4K | 0 |
| Sep 30, 2025 | Bedrosian Camille L | Chief Medical Officer | Sell | 12,039 | $14.58 | $175.5K | 0 |
| Sep 30, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 29,933 | $14.35 | $429.5K | 0 |
| Sep 30, 2025 | FRATES JAMES M | Chief Financial Officer | Sell | 10,558 | $14.65 | $154.7K | 0 |
| Sep 30, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 29,975 | $14.38 | $431.0K | 0 |
| Sep 30, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 8,828 | $14.58 | $128.7K | 0 |
| Aug 12, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 30,000 | $8.20 | $246.1K | 0 |
| Mar 31, 2025 | Bedrosian Camille L | Chief Medical Officer | Sell | 12,425 | $3.47 | $43.1K | 0 |
| Mar 31, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 21,490 | $3.47 | $74.5K | 0 |
| Mar 31, 2025 | FRATES JAMES M | Chief Financial Officer | Sell | 10,896 | $3.47 | $37.8K | 0 |
| Mar 31, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 21,490 | $3.46 | $74.5K | 0 |
| Mar 31, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 9,192 | $3.48 | $32.0K | 0 |
| Mar 20, 2025 | Zeiher Bernhardt G | Director | Buy | 10,000 | $3.70 | $37.0K | 0 |
| Mar 3, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 4,595 | $3.17 | $14.5K | 0 |
| Mar 3, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 4,595 | $3.15 | $14.5K | 0 |
| Mar 3, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 1,611 | $3.12 | $5.0K | 0 |
| Feb 24, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 4,169 | $3.15 | $13.1K | 0 |
| Feb 3, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 11,851 | $3.47 | $41.1K | 0 |
| Feb 3, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 11,855 | $3.47 | $41.1K | 0 |
| Feb 3, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 3,678 | $3.49 | $12.8K | 0 |
| Jan 6, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,471 | $4.05 | $30.2K | 0 |
| Jan 6, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 7,471 | $4.04 | $30.2K | 0 |
| Dec 2, 2024 | Bedrosian Camille L | Chief Medical Officer | Sell | 5,421 | $5.54 | $30.0K | 0 |
| Sep 30, 2024 | Bedrosian Camille L | Chief Medical Officer | Sell | 11,442 | $3.20 | $36.6K | 0 |
| Sep 30, 2024 | Klee Justin B. | Co-Chief Executive Officer | Sell | 18,589 | $3.20 | $59.4K | 0 |
| Sep 30, 2024 | Mazzariello Gina | Chief Legal Officer | Sell | 8,709 | $3.20 | $27.8K | 0 |
| Sep 12, 2024 | FRATES JAMES M | Chief Financial Officer | Buy | 40,000 | $2.53 | $101.4K | 0 |
| Sep 5, 2024 | Firestone Karen | Director | Buy | 50,000 | $2.13 | $106.6K | 0 |
| Sep 3, 2024 | MILNE GEORGE M JR | Director | Buy | 100,000 | $2.20 | $219.8K | 0 |
Showing 1–50 of 80
1 / 2
AMLX Insider Buying Activity
The following table shows recent insider purchases of Amylyx Pharmaceuticals, Inc. (AMLX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | Firestone Karen | director | Buy | 3,800 | $13.51 | $51.3K | 66,900 |
| Dec 23, 2025 | Firestone Karen | Director | Buy | 8,100 | $12.45 | $100.8K | 0 |
| Mar 20, 2025 | Zeiher Bernhardt G | Director | Buy | 10,000 | $3.70 | $37.0K | 0 |
| Sep 12, 2024 | FRATES JAMES M | Chief Financial Officer | Buy | 40,000 | $2.53 | $101.4K | 0 |
| Sep 5, 2024 | Firestone Karen | Director | Buy | 50,000 | $2.13 | $106.6K | 0 |
| Sep 3, 2024 | MILNE GEORGE M JR | Director | Buy | 100,000 | $2.20 | $219.8K | 0 |
AMLX Insider Selling Activity
The following table shows recent insider sales of Amylyx Pharmaceuticals, Inc. (AMLX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Mazzariello Gina | officer: Chief Legal Officer | Sell | 30,000 | $17.96 | $538.9K | 194,090 |
| Feb 25, 2026 | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,419 | $14.14 | $48.4K | 141,274 |
| Feb 4, 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 3,363,965 |
| Feb 4, 2026 | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 173,547 |
| Feb 4, 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 3,363,898 |
| Feb 4, 2026 | Mazzariello Gina | officer: Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 144,693 |
| Feb 2, 2026 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 0 |
| Feb 2, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 0 |
| Feb 2, 2026 | Klee Justin B. | Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 0 |
| Feb 2, 2026 | Mazzariello Gina | Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 0 |
| Jan 20, 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 3,379,465 |
| Jan 20, 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 3,379,398 |
| Jan 15, 2026 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 138,167 | $13.59 | $1.88M | 0 |
| Jan 15, 2026 | Klee Justin B. | Co-Chief Executive Officer | Sell | 138,188 | $13.59 | $1.88M | 0 |
| Jan 8, 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,632 |
| Jan 8, 2026 | FRATES JAMES M | officer: Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 177,104 |
| Jan 8, 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,586 |
| Jan 6, 2026 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 0 |
| Jan 6, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 0 |
| Dec 1, 2025 | Bedrosian Camille L | Chief Medical Officer | Sell | 6,580 | $14.35 | $94.4K | 0 |
| Sep 30, 2025 | Bedrosian Camille L | Chief Medical Officer | Sell | 12,039 | $14.58 | $175.5K | 0 |
| Sep 30, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 29,933 | $14.35 | $429.5K | 0 |
| Sep 30, 2025 | FRATES JAMES M | Chief Financial Officer | Sell | 10,558 | $14.65 | $154.7K | 0 |
| Sep 30, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 29,975 | $14.38 | $431.0K | 0 |
| Sep 30, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 8,828 | $14.58 | $128.7K | 0 |
| Aug 12, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 30,000 | $8.20 | $246.1K | 0 |
| Mar 31, 2025 | Bedrosian Camille L | Chief Medical Officer | Sell | 12,425 | $3.47 | $43.1K | 0 |
| Mar 31, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 21,490 | $3.47 | $74.5K | 0 |
| Mar 31, 2025 | FRATES JAMES M | Chief Financial Officer | Sell | 10,896 | $3.47 | $37.8K | 0 |
| Mar 31, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 21,490 | $3.46 | $74.5K | 0 |
| Mar 31, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 9,192 | $3.48 | $32.0K | 0 |
| Mar 3, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 4,595 | $3.17 | $14.5K | 0 |
| Mar 3, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 4,595 | $3.15 | $14.5K | 0 |
| Mar 3, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 1,611 | $3.12 | $5.0K | 0 |
| Feb 24, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 4,169 | $3.15 | $13.1K | 0 |
| Feb 3, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 11,851 | $3.47 | $41.1K | 0 |
| Feb 3, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 11,855 | $3.47 | $41.1K | 0 |
| Feb 3, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | 3,678 | $3.49 | $12.8K | 0 |
| Jan 6, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,471 | $4.05 | $30.2K | 0 |
| Jan 6, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | 7,471 | $4.04 | $30.2K | 0 |
| Dec 2, 2024 | Bedrosian Camille L | Chief Medical Officer | Sell | 5,421 | $5.54 | $30.0K | 0 |
| Sep 30, 2024 | Bedrosian Camille L | Chief Medical Officer | Sell | 11,442 | $3.20 | $36.6K | 0 |
| Sep 30, 2024 | Klee Justin B. | Co-Chief Executive Officer | Sell | 18,589 | $3.20 | $59.4K | 0 |
| Sep 30, 2024 | Mazzariello Gina | Chief Legal Officer | Sell | 8,709 | $3.20 | $27.8K | 0 |
AMLX Insiders
Similar Stocks to AMLX
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B